Catalyst Wire Dossier Catalyst Wire Dossier

Desmopressin ODT (orally disintegrating tablets)

desmopressin · Ferring Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Desmopressin ODT (orally disintegrating tablets), covering 2019-09-11 to 2019-09-11. Get the full timeline:

Most recent: Clinical Trial Update: Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Female Subjects [Phase 3]

See pricing